Huang Dao Chao, Papavasiliou Vasilios, Rhim Johng S, Horst Ronald L, Kremer Richard
Department of Medicine, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada.
Mol Cancer Res. 2002 Nov;1(1):56-67.
It has been previously shown that keratinocytes express a high level of 25-hydroxyvitamin D(3) (25-OHD(3)) 1alpha-hydroxylase (1alpha-hydroxylase). 1alpha-Hydroxylase catalyzes the conversion of 25-OHD(3) to 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. 1,25(OH)(2)D(3) is both antiproliferative (i.e., suppresses cell growth) and prodifferentiative (i.e., induces cell differentiation) in many cell types. We hypothesized that local production of 1,25(OH)(2)D(3) by keratinocytes may suppress their growth and induce their differentiation in an autocrine fashion. To test this hypothesis, we inactivated both 1alpha-hydroxylase alleles in a ras-transformed keratinocyte cell line, HPK1Aras, which typically produces squamous carcinoma in nude mice. To inactivate 1alpha-hydroxylase expression by HPK1Aras cells, we disrupted both alleles of the 1alpha-hydroxylase gene by homologous recombination. Lack of expression and activity of 1alpha-hydroxylase was confirmed by Northern blot analysis and detected conversion of 25-OHD(3) to 1,25(OH)(2)D(3). We then examined the effect of substrate 25-OHD(3) on parameters of growth and differentiation in the double knockout cell line as compared to wild-type HPK1Aras cells in vitro. It was found that 1alpha-hydroxylase inactivation blocked the antiproliferative and prodifferentiative effect of 25-OHD(3). These in vitro effects were further analyzed in vivo by injecting knockout or control cells subcutaneously in severely compromised immunodeficient mice. Tumor growth was accelerated and differentiation was inhibited in mice given injections of knockout cells as compared to control cells in the presence of substrate 25-OHD(3). Our results demonstrate, for the first time, that 1alpha-hydroxylase expression by keratinocytes plays an important role in autocrine growth and differentiation of these cells, and suggest that expression of this enzyme may modulate tumor growth in squamous carcinomas.
先前的研究表明,角质形成细胞表达高水平的25-羟基维生素D(3)(25-OHD(3))1α-羟化酶(1α-羟化酶)。1α-羟化酶催化25-OHD(3)转化为1α,25-二羟基维生素D(3) [1,25(OH)(2)D(3)]。在许多细胞类型中,1,25(OH)(2)D(3)具有抗增殖作用(即抑制细胞生长)和促分化作用(即诱导细胞分化)。我们推测角质形成细胞局部产生的1,25(OH)(2)D(3)可能以自分泌方式抑制其生长并诱导其分化。为了验证这一假设,我们在一种ras转化的角质形成细胞系HPK1Aras中使两个1α-羟化酶等位基因失活,该细胞系在裸鼠中通常会产生鳞状癌。为了使HPK1Aras细胞中的1α-羟化酶表达失活,我们通过同源重组破坏了1α-羟化酶基因的两个等位基因。通过Northern印迹分析证实了1α-羟化酶缺乏表达和活性,并检测到25-OHD(3)向1,25(OH)(2)D(3)的转化。然后,我们在体外研究了与野生型HPK1Aras细胞相比,底物25-OHD(3)对双敲除细胞系生长和分化参数的影响。发现1α-羟化酶失活阻断了25-OHD(3)的抗增殖和促分化作用。通过将敲除细胞或对照细胞皮下注射到严重免疫缺陷的小鼠体内,在体内进一步分析了这些体外效应。与在存在底物25-OHD(3)的情况下注射对照细胞的小鼠相比,注射敲除细胞的小鼠肿瘤生长加速且分化受到抑制。我们的结果首次证明,角质形成细胞表达的1α-羟化酶在这些细胞的自分泌生长和分化中起重要作用,并表明该酶的表达可能调节鳞状癌中的肿瘤生长。